Form 8-K - Current report:
SEC Accession No. 0001104659-20-058140
Filing Date
2020-05-07
Accepted
2020-05-07 16:34:08
Documents
5
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018917-1_8k.htm 8-K 24357
2 EXHIBIT 99.1 tm2018917d1_ex99-1.htm EX-99.1 50763
3 EXHIBIT 99.2 tm2018917d1_ex99-2.htm EX-99.2 16344
4 GRAPHIC tm2018917d1_ex99-1img001.jpg GRAPHIC 5250
5 GRAPHIC tm2018917d1_ex99-2img001.jpg GRAPHIC 5592
  Complete submission text file 0001104659-20-058140.txt   108081
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 20857030
SIC: 2834 Pharmaceutical Preparations